维普期刊资源整合服务平台（V6.5）

47篇 您的检索式：作者名="MONTAGUT C"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer 显示文摘	Pera M Gallego R Montagut C	2012	Ann Oncol2012，23，3：	1
2	PhaseⅡtrial of pre-operative chemoradiotherapy with oxaliplatin,cisplatin,and 5-FU in locally advanced esophageal and gastric cancer显示文摘	Pera M Gallego R Montagut C		0，，03：	1
3	Mitogen-activated protein kinase phosphatase-l(MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients显示文摘	Montagut C Iglesias M Arumi M	2010	Br J Cancer2010，102，7：	1
4	Present strategies in the treatment of metastatic renal cell carcinoma:an update on molecular targeting agents 显示文摘	Bellmunt J Montagut C Albiol S	2007	BJU Int2007，99，2：	1
5	Activation of nu-clear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients 显示文摘	Montagut C Tusquets I Ferrer B	2006	Endocr Relat Cancer2006，13，2：	1
6	A phase I, dose - finding study of sunitinib combined with cisplatin and 5 - fluorouracil in patients with ad- vanced gastric cancer显示文摘	G? MEZ- MART? N C1 SALAZAR R MONTAGUT C GIL- MART? N M	2013	Invest New Drugs2013，31，2：	1
7	Activation of nuclear factor- kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients显示文摘	Montagut C Tusquets I Ferrer B etal	2006	Endocr Relat Cancer2006，13，2：	1
8	Identification of a mutation in the extra-cellular domain of the epidermal growth factor receptor conferring cetuximab resistence in colorectal cancer显示文摘	Montagut C Dalmases A Bellosillo B	2012	Nat Med2012，18，2：	1
9	Identification of a mutation in the extracellular domain of the epidermal growth factor receptor conferring cetuximab resistance in colorectal cancer显示文摘	Montagut C Dalmases A Bellosillo B	2012	Nat Med2012，18，：	1
10	Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpus显示文摘	Montagut C Marmol M Rey V	2003	Cynecol Oncol2003，90，2：	1
11	Targeting the RAF-MEK-ERK pathway in cancer therapy显示文摘	Montagut C Settleman J	2009	Cancer Lett2009，283，2：	1
12	A phase Ⅰ studyof the safety and pharmacokinetics of the combination of pertuzumab (rhuMab2C4) and capecitabine in patients with advanced solid tumors显示文摘	Albanell J Montagut C Jones ET	2008	Clin Cancer Res2008，149，：	1
13	Targeting the RAF-MEK-ERK pathway in cancer therapy 显示文摘	Montagut C Settleman J	2009	Cancer Lett2009，283，2：	1
14	Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva显示文摘	Santos M Montagut C Mellado B	2004	Int J Gynecol Pathol2004，23，3：	1
15	The proteasome:a novel target for anticancer therapy显示文摘	Montagut C Rovira A Albanell J	2006	Clin Transl Oncol2006，8，5：	1
16	lmmunohistochemical staining for p16 and p53 in premalignant and malignant epithelial Lesions of the vulva显示文摘	Santos M Montagut C Mellado B	2004	Int J Gynecol Pathol2004，23，3：	1
17	Targeting the RAF-MEK-ERK pathway in cancer therapy显示文摘	Montagut C Settleman J		0，，02：	1
18	The proteasome: a novel target for anticancer therapy 显示文摘	Montagut C Rovira A Albanell J	2006	Clin Transl Oncol2006，8，5：	1
19	Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients显示文摘	Montagut C Iglesias M Arumi M		0，，7：	1
20	The proteasome: a novel target for anticancer therapy 显示文摘	Montagut C Rovira A Albanell J	2006	Clin Transl Oncol2006，8，5：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示